Results 141 to 150 of about 25,164,155 (279)

Severity-dependent proteomic alterations in the rat hippocampus following pilocarpine-induced status epilepticus. [PDF]

Mol Cell Neurosci
Soni S, Li Y, Wyatt-Johnson SK, Aryal UK, Brewster AL.   +4 more
europepmc   +1 more source

An Open‐Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's Disease

Movement Disorders, EarlyView.
Complement activation is implicated in Huntington's disease; ANX005 is a potent inhibitor of component C1q. ANX005 exhibited a generally manageable safety profile with rapid reduction in C1q in the cerebrospinal fluid. Functional ability on composite Unified Huntington's Disease Rating Scale and total functional capacity was maintained, with potential ...
Rajeev Kumar, Pinky Agarwal, Karen Anderson, Daniel Claassen, Marissa Dean, Andrew Duker, Burton Scott, Benjamin Hoehn, Ann Mongan, Ping Lin, Ellen Cahir‐McFarland, Lori Taylor, Glenn Morrison, Ted Yednock, Sanjay Keswani, Henk‐Andre Kroon   +15 more
wiley   +1 more source

The Expanding Landscape of Microbiota Medicine: Indications, Therapeutic Modalities, and the Path Towards Integrative Microbiome‐Targeting Healthcare

Microbiota Medicine Research, EarlyView.
ABSTRACT The growing recognition of the microbiome's role in human health has propelled the emergence of microbiota medicine—a new discipline integrating microbiology, multi‐omics, and clinical science. Advances in sequencing, data integration, and interventions such as fecal microbiota transplantation (FMT) have transitioned the field from ...
Min Dai, Yisha Lin, Renyou Gan, Xiaotao Shen, Shin Young Park, Sunjae Lee, Qi Su   +6 more
wiley   +1 more source

[Dermal fillers and late-onset reactions: An emerging challenge in primary care]. [PDF]

Aten Primaria
Estalayo-Gutiérrez B, Minué-Estirado M, Mateos-Camino L, Rodríguez-Tadeo G.   +3 more
europepmc   +1 more source

Gyp á travers ses Souvenirs, ses contemporains et ses biographes

Anales de Filología Francesa, 2016
Abstract: This article concerns Gyp, nom de plume of Sibylle Gabrielle Riquetti de Mirabeau, Comtesse de Martel (1849-1932), with the aim of studying the author's image ofered by herself in her memoirs (Souvenirs d'une petite flle), the author's image given by the press of her time and by her contemporaries, such as Anatole France, as well as the one ...
openaire   +2 more sources

Safety of 8‐Week Administration With Ashwagandha (Withania somnifera) Root Extract in Adults With Stress and Anxiety: Findings From a Prospective, Randomized, Multi‐Center, Double‐Blinded, Placebo‐Controlled Study

Phytotherapy Research, EarlyView.
ABSTRACT Ashwagandha (Withania somnifera) has been recognized for enhancing physical strength, mental well‐being, and overall vitality. Despite its long‐standing use across generations, some clinical reports have noted occasional adverse events. This study compared the safety and tolerability of Ashwagandha Root Extract (ARE) in healthy adults.
Ketan Pakhale, Jaising Salve, John Ademola, Jose Parraca, Deepak Langade   +4 more
wiley   +1 more source

Good mid-term outcomes and over 80% survivorship rate after all-inside repair of bucket-handle and full-thickness radial tears. [PDF]

J Exp Orthop
Dzidzishvili L, Ambrosini L, Adravanti FM, Rossi C, Neri MP, Hantouly A, Zaffagnini S, Grassi A.   +7 more
europepmc   +1 more source

Toward Sustainable Healthcare: Examining ESG‐Readiness in Austrian Regional State‐Owned Hospitals

Sustainable Development, EarlyView.
ABSTRACT Reporting on environmental, social, and governance (ESG) issues is now an essential part of responsible corporate governance, including in the healthcare sector. This study investigates the ESG reporting practices of Austrian regional state‐owned hospitals (rSOHs), contributing to the growing sustainability literature. Thirteen interviews with
Philumena Bauer, Dorothea Greiling, Hüseyin Celik, Laura Kienast   +3 more
wiley   +1 more source